Daniel Laheru

Professor

1992 …2018
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 2 Similar Profiles
Pancreatic Neoplasms Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Survival Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
irinotecan Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2018

Assessment of iodine uptake by pancreatic cancer following chemotherapy using dual-energy CT

Kawamoto, S., Fuld, M. K., Laheru, D., Huang, P. & Fishman, E. K. Feb 1 2018 In : Abdominal Radiology. 43, 2, p. 445-456 12 p.

Research output: Contribution to journalReview article

Pancreatic Neoplasms
Iodine
Drug Therapy
Cytotoxins
Therapeutics

Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer

Klein, A. P. , Wolpin, B. M. , Risch, H. A. , Stolzenberg-Solomon, R. Z. , Mocci, E. , Zhang, M. , Canzian, F. , Childs, E. J. , Hoskins, J. W. , Jermusyk, A. , Zhong, J. , Chen, F. , Albanes, D. , Andreotti, G. , Arslan, A. A. , Babic, A. , Bamlet, W. R. , Beane-Freeman, L. , Berndt, S. I. , Blackford, A. & 30 others Borges, M., Borgida, A., Bracci, P. M., Brais, L., Brennan, P., Brenner, H., Bueno-De-Mesquita, B., Buring, J., Campa, D., Capurso, G., Cavestro, G. M., Chaffee, K. G., Chung, C. C., Cleary, S., Cotterchio, M., Dijk, F., Duell, E. J., Foretova, L., Fuchs, C., Funel, N., Gallinger, S., Gaziano, J. M. M., Gazouli, M., Giles, G. G., Giovannucci, E., Goggins, M., Goodman, G. E., Goodman, P. J., Hackert, T. & Laheru, D. Dec 1 2018 In : Nature Communications. 9, 1, 556

Research output: Contribution to journalArticle

identification method
genome
meta-analysis
loci
Pancreatic Neoplasms

Is a Pathological Complete Response Following Neoadjuvant Chemoradiation Associated with Prolonged Survival in Patients with Pancreatic Cancer?

He, J., Blair, A. B., Groot, V. P., Javed, A. A., Burkhart, R. A., Gemenetzis, G., Hruban, R. H., Waters, K. M., Poling, J., Zheng, L., Laheru, D., Herman, J. M., Makary, M. A., Weiss, M. J., Cameron, J. L. & Wolfgang, C. L. Jul 1 2018 In : Annals of surgery. 268, 1, p. 1-8 8 p.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Survival
Adenocarcinoma
Disease-Free Survival
Lymph Nodes

Long-term analysis of 2 prospective studies that incorporate mitomycin C into an adjuvant chemoradiation regimen for pancreatic and periampullary cancers

Schunke, K. J., Rosati, L. M., Zahurak, M., Herman, J. M., Narang, A. K., Usach, I., Klein, A. P., Yeo, C. J., Korman, L. T., Hruban, R. H., Cameron, J. L., Laheru, D. A. & Abrams, R. A. Jan 1 2018 (Accepted/In press) In : Advances in Radiation Oncology.

Research output: Contribution to journalArticle

Mitomycin
Pancreatic Neoplasms
Fluorouracil
Prospective Studies
Survival

Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancer

Finn, R. S., Ahn, D. H., Javle, M. M., Tan, B. R., Weekes, C. D., Bendell, J. C., Patnaik, A., Khan, G. N., Laheru, D., Chavira, R., Christy-Bittel, J., Barrett, E., Sawyer, M. B. & Bekaii-Saab, T. S. May 22 2018 (Accepted/In press) In : Investigational New Drugs. p. 1-7 7 p.

Research output: Contribution to journalArticle

Biliary Tract Neoplasms
Mitogen-Activated Protein Kinase Kinases
Mutation
MEK162
Pharmacokinetics